Exercise and heart failure: A review

Chest

Volumn 110, Issue 5, 1996, Pages 1317-1327

  Piña, Ileana L ^a,b   Fitzpatrick, James T ^a  

^a TEMPLE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

cardiopulmonary testing; exercise limitations in heart failure; exercise physiology in heart failure; exercise testing; heart failure

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLOSEQUINAN;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DYSPNEA; EXERCISE; EXERCISE TEST; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART REHABILITATION; HUMAN; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKELETAL MUSCLE;

EID: 0029821388     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.5.1317     Document Type: Review

References (67)

1. Tristani FE, Hughes CV, Archibald DG, et al. Safety of graded symptom-limited exercise testing in patients with congestive heart failure. Circulation 1987; 76(suppl 6):54-8
2. Giannuzzi P, Tavazzi L, Temporelli PL, et al. Long term physical training and left ventricular remodeling after anterior myocardial infarction: results of the Exercise in Anterior Myocardial Infarction (EAMI) trial. J Am Coll Cardiol 1993; 22:1821-29
3. Giannuzzi P, Temporelli PL, Tavazzi L, et al. EAMI - exercise training in anterior myocardial infarction, an ongoing multicenter randomized study: preliminary results of left ventricular function and remodeling. Chest 1992; 101(suppl 5):315S-21S
4. Konstam M, Dracup K, Baker D, et al. Heart failure: evaluation and care of patients with left ventricular systolic dysfunction: clinical practice guideline 11. US Department of Health and Human Services, Agency for Health Care Policy and Research, AHCPR publication 94-0612; 1994
5. US Department of Health and Human Services, Agency for Health Care Policy and Research Clinical practice guideline 17, cardiac rehabilitation. AHCPR publication 96-0672; 1995
6. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981; 47:33-9
7. Franciosa JA, Ziesche S, Wylem M. Functional capacity of patients with chronic left ventricular failure. Am J Med 1979; 67:460-66
8. Piña IL, Madonna DW, Sinnamon E. Exercise test interpretation. In: Fletcher G, ed: Cardiology clinics: exercise testing and cardiac rehabilitation. 1993; 11:215-28
9. Weber TW, Wilson JR, Janicki JS, et al. Exercise testing in the evaluation of the patient with chronic cardiac failure. Am Rev Respir Dis 1984; 129:S60-S62
10. Benge W, Lichtfield RL, Marcus ML. Exercise capacity in patients with severe left ventricular function. Circulation 1980; 61:955-59
11. Szlachcic J, Massie B, Kramer B, et al. Correlates and prognostic implications of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985; 55:1037-42
12. Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplation in ambulatory patients with heart failure. Circulation 1991; 83:778-86
13. Cohn JN, Johnson GR, Shabetal R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993; 87(suppl 6):VI24-I31
14. Sullivan MJ, Knight D, Higginbotham MB, et al. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Circulation 1989; 80:769-81
15. Weber KT, Kinasewitz GT, Janicki JS, et al. Oxygen utilization during exercise in patients with chronic cardiac failure. Circulation 1982; 65:1213-23
16. Muller AF, Batin P, Evans S, et al. Regional blood in chronic heart failure: the reason for the lack of correlation between patients' exercise tolerance and cardiac output? Br Heart J 1992; 67:478-81
17. Zelis R, Longhurst J, Capone RJ, et al. A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation 1974; 50:137-43
18. Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation 1993; 87:470-75
19. Nakamura M, Chiba M, Ueshima K, et al. Impaired cholinergic peripheral vasodilation and its relationship to hyperemic calf blood flow response and exercise intolerance in patients with chronic heart failure. Int J Cardiol 1995; 48:139-46
20. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996; 93:210-14
21. Weiner DH, Fink LI, Maris J, et al. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 1986; 73:1127-36
22. Massie B, Conway M, Rajagopalan B, et al. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure: evidence for abnormalities unrelated to blood flow. Circulation 1988; 78:320-26
23. 31P-NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 1989; 80:1338-46
24. Drexler II, Faude F, Hoing S, et al. Blood flow distribution within skeletal muscle during exercise in the presence of chronic heart failure: effect of milrinone. Circulation 1987; 76:1344-52
25. Minotti JR, Pillay P, Oka R, et al. Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol 1993; 75:373-81
26. Drexler H, Reide U, Munzel T, et al. Alterations of skeletal muscle in chronic heart failure. Circulation 1992; 85:1751-59
27. Sullivan M, Green, Cobb F. Skeletal muscle biochemistry and histology in ambulatory patients with long term heart failure. Circulation 1990; 81:518-27
28. Minotti JR, Christopher I, Oka R, et al. Impaired skeletal muscle function in patients with congestive heart failure: relationship to systemic exercise performance. J Clin Invest 1991; 88:2077-82
29. Yamani MH, Sahgal P, Wells L, et al. Exercise intolerance in chronic heart failure is not associated with impaired recovery of muscle function or submaximal exercise performance. J Am Coll Cardiol 1995; 25:1232-38
30. Saltin B, Nazar K, Costill DL, et al. The nature of the training response, peripheral and central adaptations to one legged exercise. Acta Physiol Scand 1976; 96:289-305
31. Aniansson A, Muscle morphology, enzyme activity and muscle strength in elderly men and women. Clin Physiol 1981; 1:73-86
32. Aniansson A, Hedberg M, Henning GB, et al. Muscle morphology enzymatic activity and muscle strength in elderly men: a follow up study. Muscle Nerve 1986; 9:585-91
33. Francis GS, Goldsmith SR, Levine TB, et al. The neurohumorol axis in congestive heart failure. Ann Intern Med 1984; 101:370-77
34. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323:236-41
35. Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988; 77:552-59
36. Myers J, Salleh BS, Buchanan BA, et al. Ventilatory mechanisms of exercise intolerance in chronic heart failure. Am Heart J 1992; 124:710
37. Metra M, Dei Cas L, Panina G, et al. Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics. Am J Cardiol 1992; 70:622-28
38. Mancini DM, Ferraro N, Nazzaro D, et al. Respiratory muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy. J Am Coll Cardiol 1991; 18:492-98
39. Mancini DM, Henson D, Manca JL, et al. Benefit of selective respiratory muscle training on exercise capacity in patients with chronic congestive heart failure. Circulation 1995; 91:320-29
40. 2 production in heart failure: not corrected by heart transplantation [Abstract]. J Am Coll Cardiol 1994; special issue:257A
41. Massie BM, Conway M, Rajagopalan B, et al. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure: evidence for abnormalities unrelated to blood flow. Circulation 1988; 78:320-26
42. Weber KT, Janicki JS. Lactate production during maximal and submaximal exercise in patients with chronic heart failure. J Am Coll Cardiol 1985; 6:717-24
43. Page E, Cohen-Solal A, Jondeau G, et al. Comparison of treadmill and bicycle exercise in patients with chronic heart failure. Chest 1994; 106:1002-06
44. Cohn JN, Johnson GR, Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993; 87(suppl 6):VI-5-VI-16
45. Lipkin DP, Canepa-Anson R, Stephens MR, et al. Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. Br Heart J 1986; 55:439-45
46. Pollock ML, Bohannon RL, Cooper KH, et al. A comparative analysis of four protocols for maximal treadmill stress testing. Am Heart J 1976; 92:39-46
47. Piña IL, Karalis DG. Comparison of four exercise protocols using anaerobic threshold measurement of functional capacity in congestive heart failure. Am J Cardiol 1990; 65:1269-71
48. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60:2020-27
49. Lipkin DP, Seriven AJ, Crake T, et al. Six minute walking test for assessing exercise capacity in chronic heart failure. BMJ 1986; 292:653-55
50. Bittner V, Weiner DII, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction: SOLVD investigators. JAMA 1993; 270:1702-07
51. Wilson JR, Rayos G, Keoh TK, et al. Dissociation between peak exercise oxygen consumption and hemodynamic dysfunction in potential heart transplant candidates. J Am Coll Cardiol 1995; 26:429-35
52. McKelvie RS, Teo KK, McCartney N, et al. Effects of exercise training in patients with congestive heart failure: a critical review. J Am Coll Cardiol 1995; 25:789-96
53. Varnauskas E, Bergman H, Houk P, et al. Hemodynamic effects of physical training of coronary patients. Lancet 1966; 2:8-12
54. Sanne H. Exercise tolerance and physical training non selected patients after myocardial infarction. Acta Med Scand 1973; 1(suppl 1):1-124
55. Ferguson RJ, Petitclere R, Choquette G, et al. Effect of physical training on treadmill exercise capacity, collateral circulation and progression of coronary disease. Am J Cardiol 1975; 34:764-69
56. Hellerstein HK, Hornsten TR, Goldbarg AN, et al. The influence of active conditioning upon subjects with coronary artery disease. Can Med Assoc J 1967; 96:758-59
57. Lee AP, Ice R, Blessey R, et al. Long term eftects of physical training on coronary patients with impaired ventricular function. Circulation 1979; 60:1519-26
58. Conn EH, Williams RS, Wallace AG. Exercise responses before and after physical conditioning in patients with severely depressed left ventricular function. Am J Cardiol 1982; 49:296-300
59. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction. Circulation 1988; 78:506-15
60. Coats AJS, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure. Circulation 1992; 85:2119-31
61. Shemesh J, Grossman E, Peleg E, et al. Norepinephrine and atrial natriuretic peptide responses to exercise testing in rehabilitated and nonrehabilitated men with ischemic cardiomyopathy after healing of anterior wall myocardial infarction. Am J Cardiol 1995; 75:1072-74
62. Minotti JR, Johnson EC, Hudson TL, et al. Skeletal muscle response to exercise training in heart failure. J Clin Invest 1990; 86:751-58
63. Belardinelli R, Georgiou D, Scocco V, et al. Low intensity exercise training in patients with chronic heart failure. J Am Coll Cardiol 1995; 26:975-82
64. Cohn J, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325:303-310
65. Packer M, Narahara KA, Elkayam U, et al. Double-blind, placebo controlled study of the efficacy of floseqinan in patients with chronic heart failure. Principle investigators of the REFLECT study. J Am Coll Cardiol 1993; 22(1):65-72
66. Flosequinan withdrawn. Letter. Lancet 1193; 342:325
67. Stelken AM, Younis LT, Jennison SH, et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996; 27:345-52